S&P 500   4,129.09 (-0.84%)
DOW   34,039.72 (-0.34%)
QQQ   305.53 (-1.40%)
AAPL   152.03 (-1.69%)
MSFT   269.93 (+0.89%)
META   185.54 (-3.17%)
GOOGL   99.56 (-7.51%)
AMZN   100.11 (-1.96%)
TSLA   199.37 (+1.30%)
NVDA   225.27 (+1.60%)
NIO   10.69 (-2.11%)
BABA   105.76 (+0.25%)
AMD   85.71 (-0.23%)
T   19.09 (-0.83%)
F   13.47 (+0.15%)
MU   60.67 (-2.35%)
CGC   2.78 (-1.42%)
GE   81.95 (-0.19%)
DIS   111.41 (-0.20%)
AMC   5.76 (-6.80%)
PFE   43.87 (+0.64%)
PYPL   80.36 (-3.45%)
NFLX   361.88 (-0.29%)
S&P 500   4,129.09 (-0.84%)
DOW   34,039.72 (-0.34%)
QQQ   305.53 (-1.40%)
AAPL   152.03 (-1.69%)
MSFT   269.93 (+0.89%)
META   185.54 (-3.17%)
GOOGL   99.56 (-7.51%)
AMZN   100.11 (-1.96%)
TSLA   199.37 (+1.30%)
NVDA   225.27 (+1.60%)
NIO   10.69 (-2.11%)
BABA   105.76 (+0.25%)
AMD   85.71 (-0.23%)
T   19.09 (-0.83%)
F   13.47 (+0.15%)
MU   60.67 (-2.35%)
CGC   2.78 (-1.42%)
GE   81.95 (-0.19%)
DIS   111.41 (-0.20%)
AMC   5.76 (-6.80%)
PFE   43.87 (+0.64%)
PYPL   80.36 (-3.45%)
NFLX   361.88 (-0.29%)
S&P 500   4,129.09 (-0.84%)
DOW   34,039.72 (-0.34%)
QQQ   305.53 (-1.40%)
AAPL   152.03 (-1.69%)
MSFT   269.93 (+0.89%)
META   185.54 (-3.17%)
GOOGL   99.56 (-7.51%)
AMZN   100.11 (-1.96%)
TSLA   199.37 (+1.30%)
NVDA   225.27 (+1.60%)
NIO   10.69 (-2.11%)
BABA   105.76 (+0.25%)
AMD   85.71 (-0.23%)
T   19.09 (-0.83%)
F   13.47 (+0.15%)
MU   60.67 (-2.35%)
CGC   2.78 (-1.42%)
GE   81.95 (-0.19%)
DIS   111.41 (-0.20%)
AMC   5.76 (-6.80%)
PFE   43.87 (+0.64%)
PYPL   80.36 (-3.45%)
NFLX   361.88 (-0.29%)
S&P 500   4,129.09 (-0.84%)
DOW   34,039.72 (-0.34%)
QQQ   305.53 (-1.40%)
AAPL   152.03 (-1.69%)
MSFT   269.93 (+0.89%)
META   185.54 (-3.17%)
GOOGL   99.56 (-7.51%)
AMZN   100.11 (-1.96%)
TSLA   199.37 (+1.30%)
NVDA   225.27 (+1.60%)
NIO   10.69 (-2.11%)
BABA   105.76 (+0.25%)
AMD   85.71 (-0.23%)
T   19.09 (-0.83%)
F   13.47 (+0.15%)
MU   60.67 (-2.35%)
CGC   2.78 (-1.42%)
GE   81.95 (-0.19%)
DIS   111.41 (-0.20%)
AMC   5.76 (-6.80%)
PFE   43.87 (+0.64%)
PYPL   80.36 (-3.45%)
NFLX   361.88 (-0.29%)

Zimmer Biomet - ZBH Stock Forecast, Price & News

$131.15
+0.21 (+0.16%)
(As of 02/8/2023 12:51 PM ET)
Add
Compare
Today's Range
$130.12
$131.61
50-Day Range
$120.10
$130.94
52-Week Range
$100.39
$135.05
Volume
487,638 shs
Average Volume
1.78 million shs
Market Capitalization
$27.52 billion
P/E Ratio
119.23
Dividend Yield
0.75%
Price Target
$131.14

Zimmer Biomet MarketRank™ Forecast

Analyst Rating
Hold
2.21 Rating Score
Upside/​Downside
0.8% Upside
$132.18 Price Target
Short Interest
Healthy
1.12% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.33
Upright™ Environmental Score
News Sentiment
0.50mentions of Zimmer Biomet in the last 14 days
Based on 40 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
6.37%
From $7.06 to $7.51 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

294th out of 1,029 stocks

Surgical Appliances & Supplies Industry

9th out of 23 stocks

ZBH stock logo

About Zimmer Biomet (NYSE:ZBH) Stock

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. The company operates through the following segments: Americas Orthopedics, EMEA, Asia Pacific, and Americas Spine and Global Dental. The Americas Orthopedics segment consists of the U.S. market and includes other North, Central, and South American markets for the firm's orthopedic product categories. The EMEA segment focuses on Europe and includes the Middle East and African markets for all product categories except Dental. The Asia Pacific segment consists of Japan, China, and Australia and includes other Asian and Pacific markets for all product categories except Dental. The Americas Spine and Global Dental segment focuses on the U.S. market and includes other North, Central, and South American markets for the firm's spine business, and all geographic markets for its dental business. This segment is also involved in research, development engineering, medica

Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Stock News Headlines

Zimmer Biomet Beats on Earnings, Growth May be Priced In
Zimmer Biomet stock is gaining after beating expectations. However, ZBH stock was fairly valued before earnings meaning investors may need to wait on analysts
Is Zimmer Biomet a Buy Ahead of Earnings? (ZBH)
Zimmer will report Q4'22 earnings this week. The question on people's minds is if it's a buy prior to this announcement being made.
The Humble Mineral at the Heart of the EV Revolution (Not Lithium)
You may know of graphite as what's in the tip of a No. 2 pencil, but it is the key to many forms of renewable energy. Today, this humble mineral is at the epicenter of the electric car revolution. Because what most people don't know is today's EV batteries contain more than 220 pounds of graphite – more than lithium, copper or aluminum!
Zimmer Biomet (NYSE:ZBH) PT Raised to $137.00
Elon Musk Claims Solar Will Soon Power the World
The world's wealthiest person -- Elon Musk -- is a visionary investor. And he fully expects solar power to be our #1 energy source within a few decades. Utility-scale solar is already becoming the cheapest option for electricity generation globally. So with the push toward clean, renewable energy, it's no wonder solar is also becoming one of the fastest growing sectors in the U.S. stock market.
Jefferies Reaffirms Their Sell Rating on Zimmer Biomet Holdings (ZBH)
Zimmer Biomet (NYSE:ZBH) PT Raised to $142.00 at Oppenheimer
Zimmer Biomet (NYSE:ZBH) PT Raised to $145.00
Zimmer Biomet (NYSE:ZBH) Updates FY 2023 Earnings Guidance
Zimmer Biomet (NYSE:ZBH) Releases FY23 Earnings Guidance
Zimmer Biomet Sees FY23 Profit In Line With View
ZBH vs. ABT: Which Stock Is the Better Value Option?
Zimmer Biomet (ZBH) Scheduled to Post Quarterly Earnings on Friday
See More Headlines
Receive ZBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zimmer Biomet and its competitors with MarketBeat's FREE daily newsletter.

ZBH Company Calendar

Ex-Dividend for 1/31 Dividend
12/23/2022
Dividend Payable
1/31/2023
Last Earnings
2/03/2023
Today
2/08/2023
Next Earnings (Estimated)
5/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Employees
19,500
Year Founded
1927

Price Target and Rating

Average Stock Price Forecast
$132.18
High Stock Price Forecast
$155.00
Low Stock Price Forecast
$95.00
Forecasted Upside/Downside
0.0%
Consensus Rating
Hold
Rating Score (0-4)
2.21
Research Coverage
14 Analysts

Profitability

Net Income
$231.40 million
Pretax Margin
5.81%

Debt

Sales & Book Value

Annual Sales
$6.94 billion
Cash Flow
$12.97 per share
Book Value
$57.31 per share

Miscellaneous

Free Float
208,320,000
Market Cap
$27.52 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Bryan C. HansonBryan C. Hanson
    Chairman, President & Chief Executive Officer
  • Ivan Tornos
    Chief Operating Officer
  • Suketu P. Upadhyay
    Chief Financial Officer & Executive Vice President
  • Zeeshan Tariq
    Chief Information Officer & Senior Vice President
  • Angela Main
    Chief Compliance Officer & Senior Vice President













ZBH Stock - Frequently Asked Questions

Should I buy or sell Zimmer Biomet stock right now?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Zimmer Biomet in the last twelve months. There are currently 3 sell ratings, 6 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ZBH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZBH, but not buy additional shares or sell existing shares.
View ZBH analyst ratings
or view top-rated stocks.

What is Zimmer Biomet's stock price forecast for 2023?

14 equities research analysts have issued twelve-month price objectives for Zimmer Biomet's shares. Their ZBH share price forecasts range from $95.00 to $155.00. On average, they expect the company's stock price to reach $132.18 in the next twelve months. This suggests a possible upside of 0.5% from the stock's current price.
View analysts price targets for ZBH
or view top-rated stocks among Wall Street analysts.

How have ZBH shares performed in 2023?

Zimmer Biomet's stock was trading at $127.50 at the start of the year. Since then, ZBH shares have increased by 3.1% and is now trading at $131.49.
View the best growth stocks for 2023 here
.

Are investors shorting Zimmer Biomet?

Zimmer Biomet saw a decline in short interest in January. As of January 15th, there was short interest totaling 2,340,000 shares, a decline of 22.3% from the December 31st total of 3,010,000 shares. Based on an average daily trading volume, of 1,360,000 shares, the days-to-cover ratio is presently 1.7 days.
View Zimmer Biomet's Short Interest
.

When is Zimmer Biomet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 2nd 2023.
View our ZBH earnings forecast
.

How were Zimmer Biomet's earnings last quarter?

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) released its earnings results on Friday, February, 3rd. The medical equipment provider reported $1.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.83 by $0.05. The medical equipment provider earned $1.83 billion during the quarter, compared to analyst estimates of $1.76 billion. Zimmer Biomet had a net margin of 3.33% and a trailing twelve-month return on equity of 11.97%. Zimmer Biomet's quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.95 earnings per share.
Read the conference call transcript
.

How often does Zimmer Biomet pay dividends? What is the dividend yield for Zimmer Biomet?

Zimmer Biomet announced a quarterly dividend on Thursday, December 15th. Stockholders of record on Tuesday, December 27th will be paid a dividend of $0.24 per share on Tuesday, January 31st. This represents a $0.96 annualized dividend and a dividend yield of 0.73%. The ex-dividend date of this dividend is Friday, December 23rd.
Read our dividend analysis for ZBH
.

Is Zimmer Biomet a good dividend stock?

Zimmer Biomet (NYSE:ZBH) pays an annual dividend of $0.96 per share and currently has a dividend yield of 0.75%. The dividend payout ratio is 87.27%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, ZBH will have a dividend payout ratio of 12.78% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for ZBH.

What guidance has Zimmer Biomet issued on next quarter's earnings?

Zimmer Biomet issued an update on its FY23 earnings guidance on Friday, February, 3rd. The company provided earnings per share (EPS) guidance of $6.95-7.15 for the period, compared to the consensus EPS estimate of $6.99. The company issued revenue guidance of +1.5-3.5% to ~$7.04-7.18 billion, compared to the consensus revenue estimate of $7.00 billion.

What is Bryan Hanson's approval rating as Zimmer Biomet's CEO?

240 employees have rated Zimmer Biomet Chief Executive Officer Bryan Hanson on Glassdoor.com. Bryan Hanson has an approval rating of 87% among the company's employees. 66.0% of employees surveyed would recommend working at Zimmer Biomet to a friend.

What other stocks do shareholders of Zimmer Biomet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zimmer Biomet investors own include AT&T (T), Walt Disney (DIS), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Cisco Systems (CSCO), Merck & Co., Inc. (MRK), Intel (INTC), AbbVie (ABBV), NVIDIA (NVDA) and JPMorgan Chase & Co. (JPM).

What is Zimmer Biomet's stock symbol?

Zimmer Biomet trades on the New York Stock Exchange (NYSE) under the ticker symbol "ZBH."

Who are Zimmer Biomet's major shareholders?

Zimmer Biomet's stock is owned by many different retail and institutional investors. Top institutional investors include Boston Partners (1.26%), Allspring Global Investments Holdings LLC (1.02%), Ceredex Value Advisors LLC (0.60%), Swiss National Bank (0.41%), Douglas Lane & Associates LLC (0.31%) and New York State Common Retirement Fund (0.28%). Insiders that own company stock include Arthur J Higgins, Bryan C Hanson, Chad F Phipps, Sang Yi and Zuilen Wilfred Van.
View institutional ownership trends
.

How do I buy shares of Zimmer Biomet?

Shares of ZBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Zimmer Biomet's stock price today?

One share of ZBH stock can currently be purchased for approximately $131.49.

How much money does Zimmer Biomet make?

Zimmer Biomet (NYSE:ZBH) has a market capitalization of $27.59 billion and generates $6.94 billion in revenue each year. The medical equipment provider earns $231.40 million in net income (profit) each year or $1.10 on an earnings per share basis.

How many employees does Zimmer Biomet have?

The company employs 19,500 workers across the globe.

Does Zimmer Biomet have any subsidiaries?
The following companies are subsidiares of Zimmer Biomet: Abbott Spine, Beijing Montagne Medical Device Co. Ltd., Beijing Montagne Medical Device Co. Ltd., BioMet, Biomet 3i Australia Pty. Ltd., Biomet 3i Belgium N.V., Biomet 3i Benelux Holdings N.V., Biomet 3i Dental Iberica SL, Biomet 3i LLC, Biomet 3i Mexico S.A. de C.V., Biomet 3i Netherlands B.V., Biomet 3i Nordic AB, Biomet 3i Portugal Lda, Biomet 3i Switzerland GmbH, Biomet 3i Turkey, Biomet 3i UK Ltd., Biomet 3i do Brasil Comercio de Aparelhos Medicos Ltda., Biomet Acquisitions (Unlimited), Biomet Argentina SA, Biomet Australia Pty. Ltd., Biomet Biologics LLC, Biomet Brazil Medical Device Ltda., Biomet C.V., Biomet CV Holdings LLC, Biomet Cementing Technologies AB, Biomet Chile SA, Biomet China Co. Ltd., Biomet Deutschland GmbH, Biomet Deutschland Holding GmbH, Biomet Fair Lawn LLC, Biomet Finance US LLC, Biomet France Sarl, Biomet Global Supply Chain Center B.V., Biomet Healthcare Management GmbH, Biomet Holdings B.V., Biomet Hong Kong CBT Ltd., Biomet Hong Kong Holding Ltd., Biomet Hong Kong No. 1 Ltd., Biomet Inc., Biomet Insurance Ltd., Biomet International Inc., Biomet International Orthopedics LLC, Biomet Leasing Inc., Biomet Manufacturing LLC, Biomet Mexico S.A. de C.V., Biomet Microfixation B.V., Biomet Orthopedics LLC, Biomet Orthopedics Puerto Rico Inc., Biomet Spain Orthopaedics S.L., Biomet Sports Medicine LLC, Biomet Trauma LLC, Biomet U.S. Reconstruction LLC, Biomet UK Healthcare Ltd., Biomet UK Ltd., CD Diagnostics, CD Diagnostics Inc., CD Laboratories Inc., Cayenne Medical, Cayenne Medical Inc., CelgenTek Innovations Corporation, Centerpulse Ltd, Changzhou Biomet Medical Devices Co. Ltd., Citra Labs LLC, Clinical Graphics, Compression Therapy Concepts Inc., Compression Therapy Products, D.S. Comp Ltd., Dornoch Medical Systems, Dornoch Medical Systems Inc., EBI Holdings LLC, EBI LLC, EBI Medical Systems LLC, EBI Patient Care Inc., ETEX Corporation, ETEX Holdings Inc., Electro-Biology LLC, Endius, Espanormed S.L., Etex, ExtraOrtho, Hakuho Company Ltd., IC Guided Surgery SRL, Implant Concierge LLC, Implant Innovations Holdings LLC, Implex, InnoVision Inc., Interpore Cross International LLC, JERDS Luxembourg Holding Sarl, Kirschner Medical Corporation, Knee Creations, LDR Brasil Comercio Importacao e Exportacao Ltda., LDR Holding, LDR Medical Hong Kong (branch), LDR Médical S.A.S., LVB Acquisition Inc., Lanx Puerto Rico LLC , Lanx Srl, Medical Compression Systems Inc., Medtech SA, Medtech SAS, Medtech Surgical GmbH, Medtech Surgical Inc., NORMED Medizin-Technik GmbH, ORTHOsoft ULC, Ortho Transmission, Orthopaedic Advantage LLC, Ospol Participacoes Ltda., Representaciones Zimmer Inc. S. de R.L. de C.V., Respondwell, SM Re Ltd., Scandimed Holding AB, Shanghai Biomet Business Consulting Co. Ltd., Synvasive Technology, Synvasive Technology Inc., ZB COOP C.V., ZB COOP LLC, ZB Cayman (Asia) Holding Ltd., ZB Cayman Island CBT 2 Ltd., ZB Dental India Private Limited, ZB EMEA 1 LP, ZB EMEA Finance UK 1 Ltd., ZB EMEA Finance UK 2 Ltd., ZB EMEA Finance UK 3 Ltd., ZB EMEA US UK LLC, ZB Hong Kong CBT 2 Ltd., ZB Hong Kong Holding Ltd., ZB Hong Kong Ltd., ZB Manufacturing LLC, ZB UK Group Holdings Limited, ZH2LX Barbados Branch (branch), Zfx, Zfx GmbH, Zfx Innovation GmbH, Zhejiang Biomet Medical Products Co. Ltd., Zimmer (Shanghai) Medical International Trading Co. Ltd., Zimmer Asia (HK) Ltd., Zimmer Australia Holding Pty. Ltd., Zimmer Biomet (Thailand) Co. Ltd., Zimmer Biomet Asel Alarabiya Limited Company, Zimmer Biomet Asia Holding B.V., Zimmer Biomet Asia Holdings Pte. Ltd., Zimmer Biomet Austria GmbH, Zimmer Biomet BVBA, Zimmer Biomet CBT, Zimmer Biomet CBT 2, Zimmer Biomet CMF and Thoracic LLC, Zimmer Biomet Canada Inc., Zimmer Biomet Centroamerica SA, Zimmer Biomet Comp Ltd., Zimmer Biomet Denmark ApS, Zimmer Biomet Dental Canada Inc., Zimmer Biomet Dental K.K., Zimmer Biomet Deutschland GmbH, Zimmer Biomet Distribution LLC, Zimmer Biomet Finance Srl, Zimmer Biomet Finance US Holding Inc., Zimmer Biomet Finland Oy, Zimmer Biomet France Holdings SAS, Zimmer Biomet France SAS, Zimmer Biomet GK, Zimmer Biomet Global Holdings Switzerland GmbH, Zimmer Biomet Hellas SA, Zimmer Biomet Ireland Limited, Zimmer Biomet Italia Srl, Zimmer Biomet Korea Ltd., Zimmer Biomet Nederland B.V., Zimmer Biomet New Zealand Company, Zimmer Biomet Norway AS, Zimmer Biomet OUS Holdings AG, Zimmer Biomet Polska Sp. z.o.o, Zimmer Biomet Portugal Unipessoal Lda, Zimmer Biomet Pty. Ltd., Zimmer Biomet Romania S.R.L., Zimmer Biomet South Africa (Pty) Ltd., Zimmer Biomet Spain S.L., Zimmer Biomet Spine Inc., Zimmer Biomet Sweden AB, Zimmer Biomet Taiwan Co. Ltd., Zimmer Biomet UK Ltd., Zimmer Biomet US 2 Holding Inc., Zimmer CBT I Holding Inc., Zimmer CBT II Holding Inc., Zimmer CEP USA Holding Co., Zimmer CEP USA Inc., Zimmer CIS Ltd., Zimmer CV Inc., Zimmer Caribe LLC, Zimmer Cayman Islands Holding Co. Ltd., Zimmer Co-op Holdings LLC, Zimmer Colombia SAS, Zimmer Czech sro, Zimmer Dental (Shanghai) Medical Device Co. Ltd., Zimmer Dental Chile Spa, Zimmer Dental GmbH, Zimmer Dental Inc., Zimmer Dental Italy Srl, Zimmer Dental Ltd., Zimmer Dental SAS, Zimmer Finance Ireland, Zimmer France Manufacturing Sarl, Zimmer Germany Holdings GmbH, Zimmer GmbH, Zimmer GmbH Euro IP Branch (branch), Zimmer GmbH Winterthur Branch (branch), Zimmer Gulf FZ LLC, Zimmer Inc., Zimmer India Private Ltd., Zimmer International Logistics GmbH, Zimmer Investments LLC, Zimmer Knee Creations Inc., Zimmer Luxembourg II Sarl, Zimmer Luxembourg Sarl, Zimmer Manufacturing B.V., Zimmer Manufacturing B.V. (branch), Zimmer Medical Malaysia SDN BHD, Zimmer Netherlands Cooperatief U.A., Zimmer Orthobiologics Inc., Zimmer Orthopedics Manufacturing Limited, Zimmer Production Inc., Zimmer Pte. Ltd., Zimmer Slovakia sro, Zimmer Southeast Florida LLC, Zimmer Spine Next Inc., Zimmer Spine SAS, Zimmer Surgical, Zimmer Surgical Inc., Zimmer Surgical SA, Zimmer Switzerland Holdings LLC, Zimmer Switzerland Manufacturing GmbH, Zimmer Tibbi Cihazlar Sanayi ve Ticaret AS, Zimmer Trabecular Metal Technology Inc., Zimmer Trustee Ltd., Zimmer UK Limited, Zimmer US Inc., and Zimmer do Brasil Comercio Ltda..
Read More
How can I contact Zimmer Biomet?

Zimmer Biomet's mailing address is 345 EAST MAIN STREET, WARSAW IN, 46580. The official website for the company is www.zimmerbiomet.com. The medical equipment provider can be reached via phone at (574) 267-6131, via email at keri.mattox@zimmerbiomet.com, or via fax at 574-372-4988.

This page (NYSE:ZBH) was last updated on 2/8/2023 by MarketBeat.com Staff